Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 62.20
-1.60 (-2.51%)
At close: Nov 28, 2025
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 991.4 million as of November 28, 2025. Its market cap has decreased by -3.46% in one year.
Market Cap
991.40M
Enterprise Value
881.95M
Revenue
170.24M
Ranking
n/a
PE Ratio
18.15
Stock Price
62.20
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 991.40M, an increase of 408.67%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 991.40M | -3.01% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | 1.23B | 9.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 264.79B |
| Novartis AG | 200.78B |
| Lonza Group AG | 38.40B |
| Galderma Group AG | 37.87B |
| Alcon | 31.41B |
| Sandoz Group AG | 24.20B |
| Straumann Holding AG | 14.91B |
| Sonova Holding AG | 11.99B |